Older adults with chronic kidney disease (CKD) stage 3-5 have a risk for anemia. It is important to identify those at risk and develop an appropriate plan of care. This session presents an evidence-based approach to assessment and implementation of strategies aimed at achieving optimal health outcomes in this high-risk population.
Contact hours available until 9/21/2015.
Requirements for Successful Completion: Complete the learning activity in its entirety and complete the online CNE evaluation.
Conflict of Interest Disclosure: Debra Hain discloses that she serves on the advisory board for Amgen Nephrology Nursing.
Planning Committee members have no disclosures to declare.
Commercial Support and Sponsorship: No commercial support or sponsorship declared.
Accreditation Statement: This educational activity has been co-provided by Anthony J. Jannetti, Inc. and GAPNA.
Anthony J. Jannetti, Inc. is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.
Anthony J. Jannetti, Inc. is a provider approved by the California Board of Registered Nursing, provider number, CEP 5387.
Review Chronic Kidney Disease (CKD) and anemia in older adults with CKD stage 3-5.
Discuss the assessment of anemia in older adults with CKD stage 3-5.
Apply evidence-based strategies to treating anemia in older adults with CKD stage 3-5.